用于眼部药物输送的热敏现场凝:聚合物基配方的进展
Raghad Alsheikh1, Dániel Nemes2, Pálma Fehér2
1Department of Pharmaceutical Technology, Faculty of Pharmacy, University of Debrecen, Debrecen 4002, Hungary; Doctorate School of Pharmaceutical Sciences, University of Debrecen, 4032 Debrecen, Hungary.
概括
热敏的in situ凝通过在体温下从液体转化为凝来改善眼部药物输送. 这提高了药物停留时间和治疗眼睛疾病的疗效.
科学领域:
- 眼科医生 眼科 眼科
- 材料科学 材料科学 材料科学
- 药品制造 药品制造 药品制造
背景情况:
- 眼部药物输送面临着诸如快速前角膜清除,减少常规眼滴生物可用性等挑战.
- 热敏的in situ凝通过在眼睛表面温度下从液体转化为凝来提供解决方案.
研究的目的:
- 提供基于聚合物的热敏反应性眼部输送系统的全面审查.
- 讨论这些系统的机制,配方参数,以及这些系统在增强眼部药物输送方面的潜力.
主要方法:
- 对用于眼部药物输送的热敏聚合物 (poloxamers,PNIPAM,纤维素衍生物) 的文献综述.
- 对热化机制的分析,包括微粒化和微粒包装.
- 关于关键配方参数和眼睛性能的实验发现的综合.
主要成果:
- 热敏的in-situ凝增强了前角膜停留时间,延长了药物释放时间,并提高了治疗疗效.
- 关键的配方参数包括sol-gel过渡温度,风学行为,粘膜粘合和眼部生物相容性.
- 波洛克萨默,聚N-异烯胺和纤维素衍生物是这些系统的有效聚合物.
结论:
- 优化的热敏 in situ 凝可以克服眼睛的障碍,有效的药物输送.
- 这些系统对治疗前部和后部眼部疾病充满希望.
- 仔细选择配方参数对于成功的眼科治疗结果至关重要.
相关概念视频
Drug Delivery: Parenteral Route
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
Drug Delivery: Miscellaneous Routes
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs through the...
Bioavailability Enhancement: Drug Stability Enhancement and GI Retention
Improving a drug's stability in the gastrointestinal (GI) tract is paramount for enhancing its bioavailability and therapeutic effectiveness. Various strategies are employed to protect the drug from the harsh gastric milieu and to ensure its release and absorption at the desired site within the GI tract.Polymer coatings are one such method used to shield drugs from the stomach's acidic environment. By preventing premature drug release, these coatings improve the bioavailability of unstable...
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Site-Targeted Drug Delivery Systems: Polymeric Carriers
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...


